Results 221 to 230 of about 14,154 (239)

Juvenile idiopathic arthritis

Lancet, The, 2007
Angelo Ravelli, Alberto Martini
exaly  

Gouty Knee Arthritis

Journal of Clinical Case Reports Medical Images and Health Sciences, 2023
openaire   +1 more source

Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets

Nature Reviews Drug Discovery, 2011
Joon-Il Jun, Lester F Lau
exaly  

The IL-33/ST2 pathway: therapeutic target and novel biomarker

Nature Reviews Drug Discovery, 2008
Richard T Lee
exaly  

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly  

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Lancet, The, 2013
Arthur Kavanaugh, Luis Puig, Proton Rahman   +2 more
exaly  

Gouty Arthritis, Acute

2012
Philip Buttaravoli, Stephen M. Leffler
openaire   +1 more source

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Lancet, The, 2013
Gerd R Burmester, Ricardo Blanco, Gene Wallenstein   +2 more
exaly  

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Lancet, The, 2017
Roy M Fleischmann, Robert J Moots, Liza Takiya   +2 more
exaly  

Acute Gouty Arthritis

JAMA, 1982
openaire   +1 more source